ImmunoGen, Inc. is a company in the U.S. stock market and it is a holding in 36 U.S.-traded ETFs. IMGN has around 12.8M shares in the U.S. ETF market. The largest ETF holder of IMGN is the iShares Russell 2000 ETF (IWM), with approximately 3.21M shares. Investors may also find of interest that the ETF with the largest allocation to IMGN stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 1.73%. On average, U.S. ETFs allocate 0.10% of IMGN to their portfolios.
Additionally, IMGN is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with IMGN as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.